Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial

20081,397 citationsJournal Article

Authors

Good health and well-being

Published in: The Lancet

Volume 371, Issue 9617, pp. 987-997

Field-Weighted Citation Impact: 81.62